feed,title,long_url,short_url
Benzinga,FDA Requests For Additional Monitoring For Travere Therapeutics' Sparsentan In Rare Kidney Disease,https://benzinga.com/general/biotech/22/10/29268782/fda-requests-for-additional-monitoring-for-travere-therapeutics-sparsentan-in-rare-kidney-disease,https://bit.ly/3T4kF5j
Benzinga,BridgeBio Pharma Shares Preliminary Data From Gene Therapy Candidate In Ultra Rare Disorder,https://benzinga.com/general/biotech/22/10/29268781/bridgebio-pharma-shares-preliminary-data-from-gene-therapy-candidate-in-ultra-rare-disorder,https://bit.ly/3D7BTJL
